Global Health Needs Extend Beyond HIV/AIDS R&D
By Mari Serebrov Washington Editor A singular focus on HIV/AIDS and a lag in translating medical discoveries into approvable medicines could be keeping the U.S. from getting its money’s worth from R&D aimed at addressing the most pressing global health needs. While the U.S. government is the leading funder of R&D for 26 of the …